This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
search
Cell and gene therapy

CEVEC CEO talks US deals to expand business

Posted by on 13 July 2017
Share this article

Frank Ubags, CEO of CEVEC—a company offering industrial scale production of viral vectors for gene therapy firms—speaks with Scrip's Lucie Ellis about the types of deals the platform technology company is seeking and what is coming up for CEVEC in 2016. He also highlights a deal the company is looking to solidify in the coming weeks that will expand its activities in the US.

Interviewer: Lucie Ellis – Reporter, Pharma Intelligence In Vivo/Pink Sheet/Scrip
Interviewee: Frank Ubags – CEO, CEVEC Pharmaceuticals GmbH

Share this article

Sign up for Partnering, Business Development & Licensing email updates

keyboard_arrow_down